TTY Biopharm Company Limited (TPEX:4105)
75.70
+1.60 (2.16%)
Apr 2, 2025, 1:30 PM CST
TTY Biopharm Company Revenue
In the year 2024, TTY Biopharm Company had annual revenue of 5.89B TWD with 7.05% growth. TTY Biopharm Company had revenue of 1.71B in the quarter ending December 31, 2024, with 4.10% growth.
Revenue
5.89B
Revenue Growth
+7.05%
P/S Ratio
3.19
Revenue / Employee
17.23M
Employees
342
Market Cap
18.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.89B | 388.31M | 7.05% |
Dec 31, 2023 | 5.51B | 443.94M | 8.77% |
Dec 31, 2022 | 5.06B | 526.00M | 11.60% |
Dec 31, 2021 | 4.54B | 313.77M | 7.43% |
Dec 31, 2020 | 4.22B | -244.47M | -5.47% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Polaris Group | 107.00M |